Literature DB >> 21697602

Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH.

Sung Eun Kim1, Medhanit Bahta, George T Lountos, Robert G Ulrich, Terrence R Burke, David S Waugh.   

Abstract

Isothiazolidinone (IZD) heterocycles can act as effective components of protein tyrosine phosphatase (PTP) inhibitors by simultaneously replicating the binding interactions of both a phosphoryl group and a highly conserved water molecule, as exemplified by the structures of several PTP1B-inhibitor complexes. In the first unambiguous demonstration of IZD interactions with a PTP other than PTP1B, it is shown by X-ray crystallography that the IZD motif binds within the catalytic site of the Yersinia pestis PTP YopH by similarly displacing a highly conserved water molecule. It is also shown that IZD-based bidentate ligands can inhibit YopH in a nonpromiscuous fashion at low micromolar concentrations. Hence, the IZD moiety may represent a useful starting point for the development of YopH inhibitors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697602      PMCID: PMC3121299          DOI: 10.1107/S0907444911018610

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  43 in total

1.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

2.  NMR-based design and evaluation of novel bidentate inhibitors of the protein tyrosine phosphatase YopH.

Authors:  Marilisa Leone; Elisa Barile; Jesus Vazquez; Angel Mei; Donald Guiney; Russel Dahl; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2010-04-28       Impact factor: 2.817

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  Assessment of phase accuracy by cross validation: the free R value. Methods and applications.

Authors:  A T Brünger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1993-01-01

5.  A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH.

Authors:  Fa Liu; Ramin Mollaaghababa Hakami; Beverly Dyas; Medhanit Bahta; George T Lountos; David S Waugh; Robert G Ulrich; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2010-03-15       Impact factor: 2.823

6.  Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.

Authors:  Andrew P Combs
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

7.  High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.

Authors:  Lay Pheng Tan; Hao Wu; Peng-Yu Yang; Karunakaran A Kalesh; Xiaohua Zhang; Mingyu Hu; Rajavel Srinivasan; Shao Q Yao
Journal:  Org Lett       Date:  2009-11-19       Impact factor: 6.005

8.  The X-ray crystal structures of Yersinia tyrosine phosphatase with bound tungstate and nitrate. Mechanistic implications.

Authors:  E B Fauman; C Yuvaniyama; H L Schubert; J A Stuckey; M A Saper
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

9.  A ligand-induced conformational change in the Yersinia protein tyrosine phosphatase.

Authors:  H L Schubert; E B Fauman; J A Stuckey; J E Dixon; M A Saper
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

10.  Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.

Authors:  Xiao Yu; Jin-Peng Sun; Yantao He; Xiaoling Guo; Sijiu Liu; Bo Zhou; Andy Hudmon; Zhong-Yin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-03       Impact factor: 11.205

View more
  9 in total

1.  Structural analysis of human dual-specificity phosphatase 22 complexed with a phosphotyrosine-like substrate.

Authors:  George T Lountos; Scott Cherry; Joseph E Tropea; David S Waugh
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

2.  Inhibitors of the Yersinia protein tyrosine phosphatase through high throughput and virtual screening approaches.

Authors:  Xin Hu; Milos Vujanac; Noel Southall; C Erec Stebbins
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

3.  Structure of human dual-specificity phosphatase 7, a potential cancer drug target.

Authors:  George T Lountos; Brian P Austin; Joseph E Tropea; David S Waugh
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-05-20       Impact factor: 1.056

4.  Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase.

Authors:  Megan Hogan; Medhanit Bahta; Scott Cherry; George T Lountos; Joseph E Tropea; Bryan M Zhao; Terrence R Burke; David S Waugh; Robert G Ulrich
Journal:  Chem Biol Drug Des       Date:  2013-03       Impact factor: 2.817

5.  Structure of the Trypanosoma cruzi protein tyrosine phosphatase TcPTP1, a potential therapeutic target for Chagas' disease.

Authors:  George T Lountos; Joseph E Tropea; David S Waugh
Journal:  Mol Biochem Parasitol       Date:  2012-11-05       Impact factor: 1.759

6.  Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: virulence factor of Yersinia pestis.

Authors:  Alicja Kuban-Jankowska; Kamlesh K Sahu; Pawel Niedzialkowski; Magdalena Gorska; Jack A Tuszynski; Tadeusz Ossowski; Michal Wozniak
Journal:  Oncotarget       Date:  2015-07-30

7.  Aurintricarboxylic acid structure modifications lead to reduction of inhibitory properties against virulence factor YopH and higher cytotoxicity.

Authors:  Alicja Kuban-Jankowska; Kamlesh K Sahu; Magdalena Gorska; Pawel Niedzialkowski; Jack A Tuszynski; Tadeusz Ossowski; Michal Wozniak
Journal:  World J Microbiol Biotechnol       Date:  2016-08-25       Impact factor: 3.312

8.  Chicoric acid binds to two sites and decreases the activity of the YopH bacterial virulence factor.

Authors:  Alicja Kuban-Jankowska; Kamlesh K Sahu; Magdalena Gorska; Jack A Tuszynski; Michal Wozniak
Journal:  Oncotarget       Date:  2016-01-19

9.  Exploring Oxidovanadium(IV) Complexes as YopH Inhibitors: Mechanism of Action and Modeling Studies.

Authors:  Priscila G A Martins; Mattia Mori; Louise D Chiaradia-Delatorre; Angela C O Menegatti; Alessandra Mascarello; Bruno Botta; Julio Benítez; Dinorah Gambino; Hernán Terenzi
Journal:  ACS Med Chem Lett       Date:  2015-08-31       Impact factor: 4.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.